Clinical trials

  • IDARUBICIN HYDROCHLORIDE for Cancer (patients receiving anthracycline-based chemotherapy)
  • CHIKUNGUNYA VIRUS, STRAIN CHIKV LR2006-OPY1, LIVE ATTENUATED for Chikungunya
  • Ropivacaine hydrochloride for Lumbar fusion (lumbar arthrodesis)
  • (2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE for Non-small cell lung cancer|Lung cancer
  • TAFASITAMAB for Immune thrombocytopenia (ITP) | Autoimmune hemolytic anemia (AIHA)
  • TREPROSTINIL PALMITIL for Pulmonary hypertension associated with interstitial lung disease
  • brivekimig for Hidradenitis suppurativa
  • Glycopyrronium bromide; Formoterol fumarate dihydrate; Beclometasone dipropionate (anhydrous) for Asthma|Mild to moderate asthma
  • Ruxolitinib for Advanced solid tumors | Metastatic clear cell renal cell carcinoma | Colorectal carcinoma (pMMR/MSS, BRAF V600E-negative) | Pancreatic adenocarcinoma (locally advanced or metastatic)
  • AVX37-102 (therapeutic hepatitis B virus vaccine) for Hepatitis B | Chronic hepatitis B
  • Tucatinib for Breast cancer|Non-small cell lung carcinoma|Glioblastoma
  • CANNABIDIOL for Severe neurodevelopmental disorders | Self-injurious behavior